Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07226583 · ClinicalTrials.gov registry record · NA
Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07226583: Clinical Trial NA study, sponsored by Stanford University.
NCT07226583 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07226583, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study evaluates a clinician-facing decision-support toolkit designed to assist adults with type 1 diabetes in preparing for moderate-intensity exercise. The netIOB \& Exercise Toolkit (NEXT) integrates recent glucose data and insulin delivery history to provide individualized suggestions regarding exercise timing, insulin adjustments, and carbohydrate intake. Adults with type 1 diabetes will complete three supervised exercise sessions under different pre-exercise guidance approaches: (A) published consensus-based standard-of-care guidance, (B) usual personal care routines, and (C) guidance informed by the NEXT Toolkit. A healthy adult control group will complete a single supervised exercise session to provide comparative physiologic data.
Interventions
- DEVICE Continuous Glucose Monitoring
- BEHAVIORAL Usual Care (UC)
- BEHAVIORAL Standard-of-Care Guidance (SoC)
- DEVICE netIOB & Exercise Toolkit (NEXT)
- DEVICE Continuous Ketone Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-04 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07226583
The ClinicalTrials.gov registry entry for NCT07226583 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Continuous Glucose Monitoring is the first listed.
NCT07226583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07226583 about?
NCT07226583 is a clinical study titled "Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise". This study evaluates a clinician-facing decision-support toolkit designed to assist adults with type 1 diabetes in preparing for moderate-intensity exercise. The netIOB \& Exercise Toolkit (NEXT) integrates recent glucose data and insulin delivery history to provide individualized suggestions regard...
What is the current status of trial NCT07226583?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-04. Estimated completion is 2026-08.
What interventions are being tested in trial NCT07226583?
The interventions under investigation include: Continuous Glucose Monitoring (DEVICE), Usual Care (UC) (BEHAVIORAL), Standard-of-Care Guidance (SoC) (BEHAVIORAL), netIOB & Exercise Toolkit (NEXT) (DEVICE), Continuous Ketone Monitoring (DEVICE).
Who is sponsoring clinical trial NCT07226583?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.